These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8830880)

  • 1. Ritanserin-induced changes in sleep-waking phases in rats.
    Kirov R; Moyanova S
    Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power spectral electroencephalogram analysis of the effects of ritanserin in freely moving rats during quiet waking.
    Moyanova S; Kirov R; Ivanova V
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):605-11. PubMed ID: 9500124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related effect of ritanserin on the sleep-waking phases in rats.
    Kirov R; Moyanova S
    Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B; Ursin R
    Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
    Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
    Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent effect of ketanserin on the sleep-waking phases in rats.
    Kirov R; Moyanova S
    Int J Neurosci; 1998 Apr; 93(3-4):257-64. PubMed ID: 9639243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L; Ursin R
    Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theta activity in the waking EEG is a marker of sleep propensity in the rat.
    Vyazovskiy VV; Tobler I
    Brain Res; 2005 Jul; 1050(1-2):64-71. PubMed ID: 15975563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.
    Kantor S; Jakus R; Balogh B; Benko A; Bagdy G
    Br J Pharmacol; 2004 Aug; 142(8):1332-42. PubMed ID: 15265808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide-S evoked arousal with electroencephalogram slow-wave compensatory drive in rats.
    Ahnaou A; Drinkenburg WH
    Neuropsychobiology; 2012 Jun; 65(4):195-205. PubMed ID: 22538299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
    Vyazovskiy VV; Kopp C; Bösch G; Tobler I
    Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats.
    Détári L; Szentgyörgyi V; Hajnik T; Szénási G; Gacsályi I; Kukorelli T
    Psychopharmacology (Berl); 1999 Mar; 142(3):318-26. PubMed ID: 10208325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chloramphenicol on brain energy metabolism using 31P spectroscopy: influences on sleep-wake states in rat.
    Chahboune H; Mahdjoub R; Desgoutte P; Rousset C; Briguet A; Cespuglio R
    J Neurochem; 2008 Aug; 106(4):1552-62. PubMed ID: 18507739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of cadmium on the structure of the circadian cycle of waking-sleep and on the EEG in Wistar rats].
    Vataev SI; Mal'gina NA; Oganesian GA
    Zh Evol Biokhim Fiziol; 1994; 30(3):408-19. PubMed ID: 7810264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2 receptor antagonism and slow-wave sleep in major depression.
    Staner L; Kempenaers C; Simonnet MP; Fransolet L; Mendlewicz J
    Acta Psychiatr Scand; 1992 Aug; 86(2):133-7. PubMed ID: 1529736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a GABA(B) and GABA(C) receptor antagonist on sleep-waking cycle in the rat.
    Deschaux O; Froestl W; Gottesmann C
    Eur J Pharmacol; 2006 Mar; 535(1-3):177-81. PubMed ID: 16540106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.